A judge Thursday refused to block a pending $15.6 billion acquisition of MedImmune Inc. by AstraZeneca PLC, saying the purported MedImmune shareholder who filed a lawsuit could not prove he owned the company’s stock.

Montgomery County, Md., Circuit Judge Marielsa Bernard denied a request by Chris Larson, of San Diego, to halt the MedImmune-AstraZeneca deal, which is expected to close in June. A $58 per share tender offer by AstraZeneca to MedImmune shareholders was set to expire at the end of Thursday.